Lithuania - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingLithuania: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024
Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Lithuania
For the third year in a row, the Lithuanian prophylactic medicaments containing insulin market recorded decline in sales value, which decreased by X% to $X in 2023. Overall, consumption continues to indicate a perceptible descent. Over the period under review, the market attained the maximum level at $X in 2017; however, from 2018 to 2023, consumption remained at a lower figure.
Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Exports from Lithuania
In 2023, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from Lithuania; increasing by X% against the previous year. Overall, exports, however, faced a abrupt shrinkage. The pace of growth appeared the most rapid in 2015 when exports increased by X% against the previous year. Over the period under review, the exports hit record highs at X tons in 2017; however, from 2018 to 2023, the exports stood at a somewhat lower figure.
In value terms, prophylactic medicaments containing insulin exports amounted to $X in 2023. In general, exports, however, recorded a deep downturn. The most prominent rate of growth was recorded in 2017 when exports increased by X%. As a result, the exports reached the peak of $X. From 2018 to 2023, the growth of the exports remained at a lower figure.
Exports by Country
The Netherlands (X tons), Germany (X kg) and Belarus (X kg) were the main destinations of prophylactic medicaments containing insulin exports from Lithuania, with a combined X% share of total exports.
From 2012 to 2023, the biggest increases were recorded for the Netherlands (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.
In value terms, the Netherlands ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Lithuania, comprising X% of total exports. The second position in the ranking was held by Germany ($X), with an X% share of total exports. It was followed by the Czech Republic, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value to the Netherlands totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (X% per year) and the Czech Republic (X% per year).
Export Prices by Country
In 2023, the average prophylactic medicaments containing insulin export price amounted to $X per ton, shrinking by X% against the previous year. Overall, the export price, however, recorded a resilient increase. The growth pace was the most rapid in 2022 when the average export price increased by X%. As a result, the export price attained the peak level of $X per ton, and then contracted in the following year.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the UK ($X,727 per ton), while the average price for exports to Belarus ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to the UK (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Imports into Lithuania
For the third year in a row, Lithuania recorded decline in supplies from abroad of medicaments containing insulin but not antibiotics in measured doses, which decreased by X% to X tons in 2023. Over the period under review, imports continue to indicate a perceptible setback. The growth pace was the most rapid in 2015 when imports increased by X%. Over the period under review, imports reached the maximum at X tons in 2017; however, from 2018 to 2023, imports remained at a lower figure.
In value terms, prophylactic medicaments containing insulin imports reduced slightly to $X in 2023. In general, imports continue to indicate a abrupt shrinkage. The most prominent rate of growth was recorded in 2020 when imports increased by X%. Imports peaked at $X in 2017; however, from 2018 to 2023, imports remained at a lower figure.
Imports by Country
In 2023, Latvia (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Lithuania, with a X% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Latvia exceeded the figures recorded by the second-largest supplier, Germany (X tons), twofold. Slovenia (X tons) ranked third in terms of total imports with a X% share.
From 2012 to 2023, the average annual growth rate of volume from Latvia totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and Slovenia (X% per year).
In value terms, Latvia ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Lithuania, comprising X% of total imports. The second position in the ranking was held by Germany ($X), with a X% share of total imports. It was followed by the Czech Republic, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value from Latvia stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and the Czech Republic (X% per year).
Import Prices by Country
In 2023, the average prophylactic medicaments containing insulin import price amounted to $X per ton, approximately equating the previous year. Overall, the import price saw a slight setback. The pace of growth was the most pronounced in 2014 an increase of X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2015 to 2023, the average import prices remained at a lower figure.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Hungary ($X per ton), while the price for Latvia ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Hungary (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Lithuania. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
- Lithuania
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Lithuania
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
- Market Research in Lithuania
- Price for Prophylactic Medicaments Containing Insulin Lithuania
- Prophylactic Medicaments Containing Insulin Market
- Hormones Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Sterile Medical Adhesion Barrier Market